Literature DB >> 4353476

3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.

P S Schein, M G McMenamin, T Anderson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4353476

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

1.  Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin. I. Oncostatic effects in mice.

Authors:  M Hayat; C Bourut; E Chenu; J L Montero; J L Imbach; J S MacDonald; G Mathé
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

2.  In vitro comparative studies of the myelotoxicity and antitumor activity of 6-[bis-(2-chloroethyl)-amino]-6-deoxy-D-glucose versus melphalan utilizing the CFU-C and HTSCA assays.

Authors:  P Lazarus; M Dufour; G Isabel; L C Panasci
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  Cytostatic action of two nitrosoureas derived from cysteamine.

Authors:  C Bourut; E Chenu; D Godenèche; J C Madelmont; R Maral; G Mathé; G Meyniel
Journal:  Br J Pharmacol       Date:  1986-11       Impact factor: 8.739

4.  Chlorozotocin, an anti-tumour agent lacking bone marrow toxicity at therapeutic doses: effects on lymphocyte subpopulations in mice.

Authors:  R I Fisher; G L Mandell; F Bostick; M G McMenamin; T Anderson
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

5.  Therapeutic evaluation of five nitrosoureas in a human melanoma xenograft system.

Authors:  R Osieka; P Glatte; R Pannenbäcker; C G Schmidt
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

6.  New derivatives of CNC-amino acids and -oligopeptides: experimental antitumor activity.

Authors:  W J Zeller
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

7.  Chemical stability of ecomustine, a new antitumor agent in aqueous and biological media as assessed by high-performance liquid chromatography.

Authors:  I el Abed; P Roger; C Gosse; G Atassi; A Gouyette
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.